Zhitong Financial App News, Federal Pharmaceutical (03933.HK) issued an announcement. UBT48128 tablets, a Class 1 innovative drug independently developed by Federal Biotechnology (Zhuhai Hengqin) Co., Ltd., a wholly-owned subsidiary of the company, have obtained implied approval from the China National Drug Administration for clinical trials of new drugs. The acceptance numbers are CXHL2601252, CXHL2601253 and CXHL2601254.

Zhitongcaijing · 1d ago
Zhitong Financial App News, Federal Pharmaceutical (03933.HK) issued an announcement. UBT48128 tablets, a Class 1 innovative drug independently developed by Federal Biotechnology (Zhuhai Hengqin) Co., Ltd., a wholly-owned subsidiary of the company, have obtained implied approval from the China National Drug Administration for clinical trials of new drugs. The acceptance numbers are CXHL2601252, CXHL2601253 and CXHL2601254.